|
1
|
American Cancer Society, . The global
economic cost of cancer. https://www.cdc.gov/cancer/dcpc/research/update-on-cancer-deaths/index.htmJune
10–2022
|
|
2
|
American Association of Cancer Research, .
Retrieved from. https://www.aacr.org/patients-caregivers/about-cancer/what-is-cancer-researchJune
10–2022
|
|
3
|
Tsatsakis AM: Toxicological risk
assessment and multi-system health impacts from exposure. Academic
Press; 2021
|
|
4
|
International Cancer Research Partnership,
. Retrieved from. https:/www.icrpartnership.org/June 10–2022
|
|
5
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2022. CA Cancer J Clin. 72:7–33. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cancer Research UK, . Cancer risk
statistics. 2019.https://www.cancerresearchuk.org/healt
h-professional/cancer-statistics/riskMay 20–2022
|
|
7
|
Taghizadehghalehjoughi A, Hacimuftuoglu A,
Cetin M, Ugur AB, Galateanu B, Mezhuev Y, Okkay U, Taspinar N,
Taspinar M, Uyanik A, et al: Effect of metformin/irinotecan-loaded
poly-lactic-co-glycolic acid nanoparticles on glioblastoma: in
vitro and in vivo studies. Nanomedicine (Lond). 13:1595–1606. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bargahi N, Ghasemali S, Jahandar-Lashaki S
and Nazari A: Recent advances for cancer detection and treatment by
microfluidic technology, review and update. Biol Proced Online.
24:52022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Song C and Giovannucci E: Preventable
incidence and mortality of carcinoma associated with lifestyle
factors among white adults in the United States. JAMA Oncol.
2:1154–1161. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chatila R, Mansour J, Mugharbil A, Nsouli
G, O'Son L, Sayad E and Deeb ME: Epidemiology and survival of
colorectal cancer in lebanon: A sub-national retrospective
analysis. Cancer Control. 28:107327482110412212021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Aaltonen L, Johns L, Järvinen H, Mecklin
JP and Houlston R: Explaining the familial colorectal cancer risk
associated with mismatch repair (MMR)-deficient and MMR-stable
tumors. Clin Cancer Res. 13:356–361. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Karlitepe A, Ozalp O and Avci CB: New
approaches for cancer immunotherapy. Tumour Biol. 36:4075–4078.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gupta D, Bhattacharjee O, Mandal D, Sen
MK, Dey D, Dasgupta A, Kazi TA, Gupta R, Sinharoy S, Acharya K, et
al: CRISPR-Cas9 system: A new-fangled dawn in gene editing. Life
Sci. 232:1166362019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Weinstein IB and Case K: The history of
cancer research: Introducing an AACR centennial series. Cancer Res.
68:6861–6862. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Richard S: BMJ blogs. Measuring research
impact-all the rage but hard to get right. Godlee F: https://blogs.bmj.com/bmj/2018/07/30/richard-smith-measuring-research-impact-rage-hard-get-right/April
4–2023
|
|
16
|
Yabroff KR, Wu XC, Negoita S, Stevens J,
Coyle L, Zhao J, Mumphrey BJ, Jemal A and Ward KC: Association of
the COVID-19 pandemic with patterns of statewide cancer services. J
Natl Cancer Inst. 114:907–990. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
El Saghir NS, Ghanem H, El Karak F, Farhat
F, Ghosn M, Makdessi J, Chouaib K, Debs J and Tabchy AB: Management
of breast cancer patients with BRCA gene mutations in Lebanon of
the Middle East: Perspectives and challenges. Hosp Pract (1995).
49:325–329. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Elias A, Shebaby WN, Nehme B, Faour W,
Bassil BS, Hakim JE, Iskandar R, Dib-Jalbout N, Mroueh M, Daher C
and Taleb RI: In vitro and in vivo evaluation of the anticancer and
anti-inflammatory activities of 2-himachelen-7-ol isolated from
Cedrus Libani. Sci Rep. 9:128552019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bahmad HF, Chalhoub RM, Harati H,
Bou-Gharios J, Assi S, Ballout F, Monzer A, Msheik H, Araji T,
Elajami MK, et al: Tideglusib attenuates growth of neuroblastoma
cancer stem/progenitor cells in vitro and in vivo by specifically
targeting GSK-3β. Pharmacol Rep. 73:211–226. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tfayli A, Al Assaad M, Fakhri G, Akel R,
Atwi H, Ghanem H, El Karak F, Farhat F, Al Rabi K, Sfeir P, et al:
Neoadjuvant chemotherapy and Avelumab in early stage resectable
nonsmall cell lung cancer. Cancer Med. 9:8406–8411. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries, CA: a cancer journal for clinicians.
74:229–263. 2024.PubMed/NCBI
|
|
22
|
Republic of Lebanon Ministry of Public
Health, . National Cancer Registry. https://moph.gov.lb/en/Pages/8/19526/national-cancer-registryMay
16–2022
|
|
23
|
Baron S and Russell-Bennett R: Editorial:
Beyond publish or perish: The importance of citations and how to
get them. J Serv Mark. 30:257–260. 2016. View Article : Google Scholar
|
|
24
|
Jaafar R, Pereira V, Saab S and El-Kassar
AN: Which journal ranking list? A case study in business and
economics. EuroMed J Bus. 16:361–380. 2021. View Article : Google Scholar
|
|
25
|
Jayaraj R, Raymond G, Krishnan S, Tzou KS,
Baxi S, Ram MR, Govind SK, Chandramoorthy HC, Abu-Khzam FN and Shaw
P: Clinical theragnostic potential of diverse miRNA expressions in
prostate cancer: A systematic review and meta-analysis. Cancers
(Basel). 12:11992020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Khalife H, Skafi N, Fayyad-Kazan M and
Badran B: MicroRNAs in breast cancer: New maestros defining the
melody. Cancer Genet. 246–247. 18–40. 2020.PubMed/NCBI
|
|
27
|
Elias-Rizk T, El Hajj J, Segal-Bendirdjian
E and Hilal G: The long non coding RNA H19 as a biomarker for
breast cancer diagnosis in Lebanese women. Sci Rep. 10:222282020.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Khazzaka A, Rassy E, Sleiman Z, Boussios S
and Pavlidis N: Systematic review of fetal and placental metastases
among pregnant patients with cancer. Cancer Treat Rev.
104:1023562022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Atat OE, Farzaneh Z, Pourhamzeh M, Taki F,
Abi-Habib R, Vosough M and El-Sibai M: 3D modeling in cancer
studies. Hum Cell. 35:23–36. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sacca L, Maroun V and Khoury M: Predictors
of high trust and the role of confidence levels in seeking
cancer-related information. Inform Health Soc Care. 47:53–61. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Karam L, Abou Staiteieh S, Chaaban R,
Hayar B, Ismail B, Neipel F, Darwiche N and Abou Merhi R:
Anticancer activities of parthenolide in primary effusion lymphoma
preclinical models. Mol Carcinog. 60:567–581. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hoteit M, Oneissi Z, Reda R, Wakim F,
Zaidan A, Farran M, Abi-Khalil E and El-Sibai M: Cancer
immunotherapy: A comprehensive appraisal of its modes of
application. Oncol Lett. 22:6552021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jaafar W, Zaherddine V, Hussein F, Saliba
NA and Hayeck N: Poor regulation implications in a low and middle
income country based on PAH source apportionment and cancer risk
assessment. Environ Sci Process Impacts. 23:1986–1996. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chaftari P, Qdaisat A, Chaftari AM,
Maamari J, Li Z, Lupu F, Raad I, Hachem R, Calin G and Yeung SJ:
Prognostic value of procalcitonin, C-reactive protein, and lactate
levels in emergency evaluation of cancer patients with suspected
infection. Cancers (Basel). 13:40872021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Massoud M, Ikdais W, Zeghondy J and Saad
A: Provision of lifestyle recommendations to cancer patients:
Results of a nationally representative survey of
hematologists/oncologists. J Cancer Educ. 36:702–709. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Alrubai T, Khalil AM, Zaki R, Sinno L and
Al Tabbah S: The psychological health of patients diagnosed with
cancer in Iraq during the COVID-19 pandemic: A single center study.
Psychooncology. 31:649–660. 2022. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Khaled K, Hundley V, Bassil M, Bazzi M and
Tsofliou F: Validation of the European prospective investigation
into cancer (EPIC) FFQ for use among adults in Lebanon. Public
Health Nutr. 24:4007–4016. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Al-Koussa H, El Mais N, Maalouf H,
Abi-Habib R and El-Sibai M: Arginine deprivation: A potential
therapeutic for cancer cell metastasis? A review. Cancer Cell Int.
20:1502020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Diab S, Yu M and Wang S: CDK7 inhibitors
in cancer therapy: The sweet smell of success? J Med Chem.
63:7458–7474. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bechnak L, Khalil C, Kurdi RE, Khnayzer R
and Patra D: Curcumin encapsulated colloidal amphiphilic block
co-polymeric nanocapsules: Colloidal nanocapsules enhance
photodynamic and anticancer activities of curcumin. Photochem
Photobiol Sci. 19:1088–1098. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hrusak O, Kalina T, Wolf J, Balduzzi A,
Provenzi M, Rizzari C, Rives S, Del Pozo Carlavilla M, Alonso MEV,
Domínguez-Pinilla N, et al: Flash survey on severe acute
respiratory syndrome coronavirus-2 infections in paediatric
patients on anticancer treatment. Eur J Cancer. 132:11–16. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Nassour C, Barton SJ, Nabhani-Gebara S,
Saab Y and Barker J: Occurrence of anticancer drugs in the aquatic
environment: A systematic review. Environ Sci Pollut Res Int.
27:1339–1347. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mehanna S, Bodman-Smith K, Daher CF and
Khnayzer RS: Rapid quantification of ruthenium(ii) polypyridyl
anti-cancer drugs using a selective ligand dissociation LC-MS/MS
method. Anal Methods. 12:4517–4525. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Assi R, Kotecki N and Awada A: Targeting
molecular subtypes in solid cancers: Successes and failures. Curr
Opin Oncol. 32:488–493. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
El Baba N, Farran M, Khalil EA, Jaafar L,
Fakhoury I and El-Sibai M: The role of Rho GTPases in VEGF
signaling in cancer cells. Anal Cell Pathol (Amst).
2020:20972142020.PubMed/NCBI
|
|
46
|
Doumit MAA, Rahi AC, Saab R and Majdalani
M: Spirituality among parents of children with cancer in a Middle
Eastern country. Eur J Oncol Nurs. 39:21–27. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bar-Sela G, Schultz MJ, Elshamy K,
Rassouli M, Ben-Arye E, Doumit M, Gafer N, Albashayreh A, Ghrayeb
I, Turker I, et al: Training for awareness of one's own
spirituality: A key factor in overcoming barriers to the provision
of spiritual care to advanced cancer patients by doctors and
nurses. Palliat Support Care. 17:345–352. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Al Hageh C, Al Assaad M, El Masri Z,
Samaan N, El-Sibai M, Khalil C and Khnayzer RS: A long-lived
cuprous bis-phenanthroline complex for the photodynamic therapy of
cancer. Dalton Trans. 47:4959–4967. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Moghnieh R, Kanafani ZA, Hanna PA, Matar
MJ, Mokhbat J, Jradeh M, Yared N, Husni R, Abdallah D, Atoui R, et
al: 2016 Lebanese society of infectious diseases and clinical
microbiology guidelines on the management of febrile neutropenia in
adult cancer patients in the ERA of growing antimicrobial
resistance. J Med Liban. 65:63–82. 2017.
|
|
50
|
Doumit MAA and Khoury MN: Facilitating and
hindering factors for coping with the experience of having a child
with cancer: A Lebanese perspective. J Psychosoc Oncol. 35:346–361.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Abd El Razik HA, Mroueh M, Faour WH,
Shebaby WN, Daher CF, Ashour HMA and Ragab HM: Synthesis of new
pyrazolo[3,4-d]pyrimidine derivatives and evaluation of their
anti-inflammatory and anticancer activities. Chem Biol Drug Des.
90:83–96. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Liu S, Abboud MI, John T, Mikhailov V,
Hvinden I, Walsby-Tickle J, Liu X, Pettinati I, Cadoux-Hudson T,
McCullagh JSO and Schofield CJ: Roles of metal ions in the
selective inhibition of oncogenic variants of isocitrate
dehydrogenase 1. Commun Biol. 4:12432021. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Bar-Sela G, Schultz MJ, Elshamy K,
Rassouli M, Ben-Arye E, Doumit M, Gafer N, Albashayreh A, Ghrayeb
I, Turker I, et al: Human development index and its association
with staff spiritual care provision: A Middle Eastern oncology
study. Support Care Cancer. 27:3601–3610. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Chemaly R, Diab S, Khazen G and Al-Hajj G:
Gastroesophageal cancer after gastric bypass surgeries: A
systematic review and meta-analysis. Obes Surg. 32:1300–1311. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Assouad E, El Hage S, Safi S, El Kareh A,
Mokled E and Salameh P: Kidney cancer trends and risk factors in
Lebanon: A 12-year epidemiological study. Cancer Causes Control.
33:303–312. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Swayden M, Bekdash A, Fakhoury I, El-Atat
O, Borjac-Natour J, El-Sibai M and Abi-Habib RJ: Activation of
autophagy following [HuArgI (Co)-PEG5000]-induced arginine
deprivation mediates cell death in colon cancer cells. Hum Cell.
34:152–164. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Nader R, Tannoury E, Rizk T and Ghanem H:
Atezolizumab-induced encephalitis in a patient with metastatic
breast cancer: A case report and review of neurological adverse
events associated with checkpoint inhibitors. Autops Case Rep.
11:e20212612021. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
El-Mais N, Fakhoury I, Al Haddad M, Nohra
S, Abi-Habib R and El-Sibai M: Human recombinant arginase I
[HuArgI(Co)-PEG5000]-induced arginine depletion inhibits pancreatic
cancer cell migration and invasion through autophagy. Pancreas.
50:1187–1194. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Khater AR and Abou-Antoun T: Mesenchymal
epithelial transition factor signaling in pediatric nervous system
tumors: Implications for malignancy and cancer stem cell
enrichment. Front Cell Dev Biol. 9:6541032021. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Atallah D, Arab W, Dagher B, Khalil N, El
Rawadi E, Atallah B, Ghaname W, El Kassis N, Chahine G and Moubarak
M: Predictive factors of lymph node metastasis and pattern of
repartition in patients with epithelial ovarian cancer. Future
Oncol. 17:5093–5101. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
El-Chami D, Al-Haddad M, Abi-Habib R and
El-Sibai M: Recombinant anthrax lethal toxin inhibits cell motility
and invasion in breast cancer cells through the dysregulation of
Rho GTPases. Oncol Lett. 21:1632021. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Hilal L, Hakim A, El-Chediak A, Temraz S,
Mukherji D, El-Husseini Z and Shamseddine A: Rectal cancer in
patients younger than 40: Tumor characteristics and comparative
survival based on a single institution. Current Cancer Therapy
Reviews. 17:244–250. 2021. View Article : Google Scholar
|
|
63
|
Jaafar L, Fakhoury I, Saab S, El-Hajjar L,
Abou-Kheir W and El-Sibai M: StarD13 differentially regulates
migration and invasion in prostate cancer cells. Hum Cell.
34:607–623. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Fayad C, Audi H, Khnayzer RS and Daher CF:
The anti-cancer effect of series of strained photoactivatable
Ru(II) polypyridyl complexes on non-small-cell lung cancer and
triple negative breast cancer cells. J Biol Inorg Chem. 26:43–55.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Khalil N and Abi-Habib RJ: [HuArgI
(co)-PEG5000]-induced arginine deprivation leads to autophagy
dependent cell death in pancreatic cancer cells. Invest New Drugs.
38:1236–1246. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Idriss M, Hodroj MH, Fakhoury R and Rizk
S: Beta-tocotrienol exhibits more cytotoxic effects than
gamma-tocotrienol on breast cancer cells by promoting apoptosis via
a P53-independent PI3-kinase dependent pathway. Biomolecules.
10:5772020. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Nasreddine G, El-Sibai M and Abi-Habib RJ:
Cytotoxicity of [HuArgI (co)-PEG5000]-induced arginine deprivation
to ovarian cancer cells is autophagy dependent. Invest New Drugs.
38:10–19. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Bahmad HF, Elajami MK, El Zarif T,
Bou-Gharios J, Abou-Antoun T and Abou-Kheir W: Drug repurposing
towards targeting cancer stem cells in pediatric brain tumors.
Cancer Metastasis Rev. 39:127–148. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
El Joumaa MM, Taleb RI, Rizk S and Borjac
JM: Protective effect of Matricaria chamomilla extract against
1,2-dimethylhydrazine-induced colorectal cancer in mice. J
Complement Integr Med. 17:2020. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Tannous S, Haykal T, Dhaini J, Hodroj MH
and Rizk S: The anti-cancer effect of flaxseed lignan derivatives
on different acute myeloid leukemia cancer cells. Biomed
Pharmacother. 132:1108842020. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Younes M, Ammoury C, Haykal T, Nasr L,
Sarkis R and Rizk S: The selective anti-proliferative and
pro-apoptotic effect of A. Cherimola on MDA-MB-231 breast cancer
cell line. BMC Complement Med Ther. 20:3432020. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Ghali RM, Mahjoub S, Zaied S, Bhiri H,
Bahia W, Mahjoub T and Almawi WV: Association of genetic variants
in NF-kB with susceptibility to breast cancer: A case control
study. Pathol Oncol Res. 25:1395–1400. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Bahmad HF, Chamaa F, Assi S, Chalhoub RM,
Abou-Antoun T and Abou-Kheir W: Cancer stem cells in neuroblastoma:
Expanding the therapeutic frontier. Front Mol Neurosci. 12:1312019.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Al-Koussa H, Al-Haddad M, Abi-Habib R and
El-Sibai M: Human recombinant arginase I [HuArgI
(Co)-PEG5000]-induced arginine depletion inhibits colorectal cancer
cell migration and invasion. Int J Mol Sci. 20:60182019. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Henaine AM, Chahine G, Massoud M, Salameh
P, Awada S, Lahoud N, Elias E, Salem M, Ballout S, Hartmann D, et
al: Management of patients with metastatic colorectal cancer in
Lebanese hospitals and associated direct cost: A multicentre cohort
study. East Mediterr Health J. 25:481–494. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Cianci S, Rumolo V, Rosati A, Scaletta G,
Alletti SG, Cerentini TM, Sleiman Z, Lordelo P, Angerame D,
Garganese G, et al: Sarcopenia in ovarian cancer patients,
oncologic outcomes revealing the importance of clinical nutrition:
Review of literature. Curr Pharm Des. 25:2480–2490. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Abou Najem S, Khawaja G, Hodroj MH and
Rizk S: Synergistic effect of epigenetic inhibitors decitabine and
suberoylanilide hydroxamic acid on colorectal cancer in vitro. Curr
Mol Pharmacol. 12:281–300. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
El-Amm J and Aragon-Ching JB: The current
landscape of treatment in non-metastatic castration-resistant
prostate cancer. Clin Med Insights Oncol. 13:11795549198339272019.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Hoter A, Rizk S and Naim HY: The multiple
roles and therapeutic potential of molecular chaperones in prostate
cancer. Cancers (Basel). 11:11942019. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Al Saud N, Jabbour S, Kechichian E,
Aderian SS, Boccara D, Nasr M, El Hachem L and Mimoun M: A
systematic review of zosteriform rash in breast cancer patients: An
objective proof of flap reinnervation and a management algorithm.
Ann Plast Surg. 81:456–461. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Bedoui SA, Barbirou M, Stayoussef M,
Dallel M, Mokrani A, Makni L, Mezlini A, Bouhaouala B,
Yacoubi-Loueslati B and Almawi WY: Association of interleukin-17A
polymorphisms with the risk of colorectal cancer: A case-control
study. Cytokine. 110:18–23. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Ghali RM, Al-Mutawa MA, Al-Ansari AK,
Zaied S, Bhiri H, Mahjoub T and Almawi WY: Differential association
of ESR1 and ESR2 gene variants with the risk of breast cancer and
associated features: A case-control study. Gene. 651:194–199. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Al Hassan M, Fakhoury I, El Masri Z,
Ghazale N, Dennaoui R, El Atat O, Kanaan A and El-Sibai M:
Metformin treatment inhibits motility and invasion of glioblastoma
cancer cells. Anal Cell Pathol (Amst). 2018:59174702018.PubMed/NCBI
|
|
84
|
Nader R, El Amm J and Aragon-Ching JB:
Role of chemotherapy in prostate cancer. Asian J Androl.
20:221–229. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Daaboul HE, Daher CF, Bodman-Smith K,
Taleb RI, Shebaby WN, Boulos J, Dagher C, Mroueh MA and El-Sibai M:
Antitumor activity of β-2-himachalen-6-ol in colon cancer is
mediated through its inhibition of the PI3K and MAPK pathways. Chem
Biol Interact. 275:162–170. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Abou-Antoun TJ, Hale JS, Lathia JD and
Dombrowski SM: Brain cancer stem cells in adults and children: Cell
biology and therapeutic implications. Neurotherapeutics.
14:372–384. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Najar M, Fayyad-Kazan H, Faour WH, Badran
B, Journe F and Lagneaux L: Breast cancer cells and bone marrow
mesenchymal stromal cells: A regulated modulation of the breast
tumor in the context of immune response. Inflamm Res. 66:129–139.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Salem C, Atallah D, Safi J, Chahine G,
Haddad A, El Kassis N, Maalouly LM, Moubarak M, Dib M and Ghossain
M: Breast density and breast cancer incidence in the lebanese
population: results from a retrospective multicenter study. Biomed
Res Int. 2017:75949532017. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
El-Amm J, Nassabein R and Aragon-Ching JB:
Impact of abiraterone on patient-related outcomes in metastatic
castration-resistant prostate cancer: Current perspectives. Cancer
Manag Res. 9:299–306. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Shebaby WN, Mroueh MA, Boukamp P, Taleb
RI, Bodman-Smith K, El-Sibai M and Daher CF: Wild carrot
pentane-based fractions suppress proliferation of human HaCaT
keratinocytes and protect against chemically-induced skin cancer.
BMC Complement Altern Med. 17:362017. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Centre for Reviews & Dissemination.
Systematic Reviews, . CRD's Guidance for Undertaking Reviews in
Healthcare. University of York; York, UK: pp. 78–108. 2008
|
|
92
|
Dang D, Dearholt S, Bissett K, Ascenzi J
and Whalen M: Johns Hopkins evidence-based practice for nurses and
healthcare professionals: Model and guidelines. 4th ed. Sigma Theta
Tau International; 2022
|
|
93
|
Cekanova M and Rathore K: Animal models
and therapeutic molecular targets of cancer: Utility and
limitations. Drug Des Devel Ther. 8:1911–1921. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Ferreira D, Adega F and Chaves R: The
importance of cancer cell lines as in vitro models in cancer
methylome analysis and anticancer drugs testing. InTech; 2013,
View Article : Google Scholar
|
|
95
|
Godskesen T, Hansson MG, Nygren P, Nordin
K and Kihlbom U: Hope for a cure and altruism are the main motives
behind participation in phase 3 clinical cancer trials. Eur J
Cancer Care (Engl). 24:133–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Hanna CR, Boyd KA and Jones RJ: Evaluating
cancer research impact: Lessons and examples from existing reviews
on approaches to research impact assessment. Health Res Policy Sys.
19:362021. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Boutros P and Fakih A: Drivers of Research
Outcomes in Developing Countries: The Case of Lebanon. Economie.
10:582022. View Article : Google Scholar
|
|
98
|
LAU website, . https://dira.lau.edu.lb/images/Factbook%202017-2018%20-General%20Information.pdfMay
30–2023
|
|
99
|
Haffar D: LAU strategy yields a marked
rise in research output. 2022. https://news.lau.edu.lb/2022/lau-strategy-yields-a-marked-rise-in-research-output.php#:~:text=In%20terms%20of%20quality%2C%20LAU,over%20the%20past%2025%20yearsMay
30–2022
|
|
100
|
Mattiuzzi C and Lippi G: Current cancer
epidemiology. J Epidemiol Glob Health. 9:217–222. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Cancer Research UK: Current Clinical Trial
Research. https://www.cancerresearchuk.org/ourresearch-by-cancer-topic/our-clinical-trialresearch/current-clinical-trial-researchMay
30–2022
|
|
102
|
Dabin K: Our mutual fiends: Cancer
Research in a time of COVID-19. Interface Focus. 11:202100522021.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Janowitz T and Tuveson DA: The era of
COVID-19 and the rise of science collectivism in cancer research.
Cancer Discov. 10:913–915. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Bizri AR, Khachfe HH, Fares MY and
Musharrafieh U: COVID-19 pandemic: An insult over injury for
Lebanon. J Community Health. 46:487–493. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Bouri E, Cepni O, Gabauer D and Gupta R:
Return connectedness across asset classes around the COVID-19
outbreak. Int Rev Fin Anal. 73:1016462020. View Article : Google Scholar
|
|
106
|
Fares MY, Salhab HA, Khachfe HH and
Khachfe HM: Breast cancer epidemiology among Lebanese women: An
11-year analysis. Medicina (Kaunas). 55:4632019. View Article : Google Scholar : PubMed/NCBI
|
